Cargando…
SAT469 Risk Factors for Relapse in Graves’ Disease and the Clinical Outcomes of Radioactive Iodine Treatment in Relapsed Cases
Disclosure: L. WingChing: None. X. Khor: None. F. Carter: None. Q. Ashcroft: None. V. Chandrabalan: None. P. M Joseph: None. Authors: Li Wing Ching, Xiao Ying Khor, Frederick Carter, Ashcroft Quinta, Vishnu Chandrabalan, Joseph Pappachan. Background: Relapse of Graves’ disease occurs in ≈50% of case...
Autores principales: | WingChing, Li, ying Khor, Xiao, Carter, Frederick, Ashcroft, Quinta, Chandrabalan, Vishnu, Joseph, Pappachan M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553543/ http://dx.doi.org/10.1210/jendso/bvad114.1943 |
Ejemplares similares
-
SAT-427 Quality of Life Following Treatment for Graves’ Disease: A Comparison of Radioactive Iodine Ablation and Surgery
por: Rowe, Christopher W, et al.
Publicado: (2020) -
SAT-601 Navigating The Storm: A Case of Thyroid Storm and Recurrent Grave's Disease after Radioactive Iodine Therapy
por: Parikh, Foram, et al.
Publicado: (2019) -
SAT520 Efficacy of Radioactive Iodine Redifferentiation Therapy in Previously Iodine Refractory Differentiated Thyroid Cancers
por: Toro-Tobon, David, et al.
Publicado: (2023) -
A Case for Lithium Pretreatment Prior to Radioactive Iodine Ablation in Grave’s Disease
por: Thakkar, Aditi, et al.
Publicado: (2021) -
FRI494 Ischemic Stroke After Radioactive Iodine Therapy In Graves Disease
por: Rave, Talia, et al.
Publicado: (2023)